| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PNAS..11013091B |
| P356 | DOI | 10.1073/PNAS.1302507110 |
| P3181 | OpenCitations bibliographic resource ID | 2857988 |
| P932 | PMC publication ID | 3740859 |
| P698 | PubMed publication ID | 23878224 |
| P50 | author | Carla V. Rothlin | Q41071298 |
| P2093 | author name string | Sourav Ghosh | |
| Nicola Gagliani | |||
| Leonel Joannas | |||
| Lidia Bosurgi | |||
| Victor Delgado Cuevas | |||
| Carmen J. Booth | |||
| Edward T. Schmid | |||
| Jochem H. Bernink | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase | Q24310364 | ||
| Cloning and mRNA expression analysis of a novel human protooncogene, c-mer | Q24319969 | ||
| Twist mediates suppression of inflammation by type I IFNs and Axl | Q28509359 | ||
| Tyro-3 family receptors are essential regulators of mammalian spermatogenesis | Q28585555 | ||
| TAM receptors are pleiotropic inhibitors of the innate immune response | Q28592484 | ||
| Alternative activation of macrophages: an immunologic functional perspective | Q29614353 | ||
| IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer | Q29614594 | ||
| Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
| Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages | Q29620142 | ||
| A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
| Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion | Q30408786 | ||
| MERTK receptor tyrosine kinase is a therapeutic target in melanoma. | Q30539324 | ||
| T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response | Q33595572 | ||
| Inflammation and oncogenesis: a vicious connection | Q33653294 | ||
| Immunobiology of the TAM receptors | Q33796991 | ||
| Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. | Q34411406 | ||
| The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma | Q34515144 | ||
| Ulcerative colitis and colorectal cancer. A population-based study | Q34634203 | ||
| Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes | Q34650719 | ||
| The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies | Q34772160 | ||
| TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer | Q34794927 | ||
| Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation | Q35083309 | ||
| Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity | Q35111750 | ||
| Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma | Q35486521 | ||
| Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells | Q35615917 | ||
| Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors | Q35927501 | ||
| Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer | Q36128435 | ||
| Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction | Q36301713 | ||
| An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance | Q36597042 | ||
| Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics | Q37203741 | ||
| A protective function for interleukin 17A in T cell-mediated intestinal inflammation | Q37260173 | ||
| Organ- and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs | Q37659042 | ||
| Inflammation and colon cancer | Q37737408 | ||
| TAM receptor signaling and autoimmune disease | Q37804572 | ||
| Targeting Axl and Mer kinases in cancer | Q37936028 | ||
| Regulation of NF-κB by deubiquitinases | Q37995682 | ||
| Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease | Q38450732 | ||
| Differential expression of Axl and correlation with invasion and multidrug resistance in cancer cells | Q39366947 | ||
| The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target. | Q39381139 | ||
| AXL regulates mesothelioma proliferation and invasiveness | Q39623714 | ||
| An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies | Q39684120 | ||
| Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors | Q40256784 | ||
| Chemically induced mouse models of intestinal inflammation | Q42510602 | ||
| R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer | Q43166849 | ||
| Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme | Q46825520 | ||
| Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-kappaB transcriptional activat | Q46881381 | ||
| Axl, a novel receptor tyrosine kinase isolated from chronic myelogenous leukemia. | Q53022023 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colon cancer | Q18555025 |
| MER proto-oncogene tyrosine kinase | Q21987691 | ||
| AXL receptor tyrosine kinase | Q21991362 | ||
| P304 | page(s) | 13091–13096 | |
| P577 | publication date | 2013-08-06 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer | |
| P478 | volume | 110 |
| Q26863442 | AXL kinase as a novel target for cancer therapy |
| Q26825957 | Advances in targeted therapies and new promising targets in esophageal cancer |
| Q58801154 | An immunological perspective for preventing cancer with berries |
| Q40062737 | Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function |
| Q33591281 | Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma |
| Q34619118 | Axl as a mediator of cellular growth and survival |
| Q54297620 | Axl inhibition: a potential road to a novel acute myeloid leukemia therapy? |
| Q35872028 | Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma |
| Q36287092 | Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma |
| Q45848920 | Cigarette Smoking Triggers Colitis by IFN-γ+ CD4+ T Cells |
| Q49691927 | Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis. |
| Q30276066 | Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis. |
| Q91884309 | Coagulopathies and inflammatory diseases: '…glimpse of a Snark' |
| Q38834628 | Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammation |
| Q39221260 | Diversity and functions of intestinal mononuclear phagocytes |
| Q87179773 | Epithelial-mesenchymal transition: a new target in anticancer drug discovery |
| Q85717127 | First Axl inhibitor enters clinical trials |
| Q92187401 | Funerals and Feasts: The Immunological Rites of Cell Death |
| Q93081121 | Gas6 Prevents Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells via Production of PGE2, PGD2 and Their Receptors |
| Q35977791 | Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation |
| Q38772267 | Giving AXL the axe: targeting AXL in human malignancy |
| Q37545045 | Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies |
| Q38605374 | Innate lymphoid cells in intestinal immunity and inflammation |
| Q39157476 | Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies |
| Q37012644 | Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis |
| Q28072503 | Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response |
| Q51315488 | Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice. |
| Q62485192 | Loss of the TAM Receptor Axl Ameliorates Severe Zika Virus Pathogenesis and Reduces Apoptosis in Microglia |
| Q40216222 | Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. |
| Q98735453 | Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress |
| Q38936695 | Microenvironmental Effects of Cell Death in Malignant Disease. |
| Q41012558 | Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis. |
| Q43097066 | Phagocytosis imprints heterogeneity in tissue-resident macrophages. |
| Q28081044 | Phagocytosis of apoptotic cells in homeostasis |
| Q36113481 | Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases |
| Q94547253 | Regulation of efferocytosis as a novel cancer therapy |
| Q49897721 | Rethinking Phagocytes: Clues from the Retina and Testes |
| Q44357991 | Signalling: Seeing the big picture |
| Q48284666 | Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction. |
| Q37696310 | Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling |
| Q47212014 | Synovial tissue macrophages: friend or foe? |
| Q33838054 | TAM Receptors Are Not Required for Zika Virus Infection in Mice |
| Q35819380 | TAM receptor signaling in immune homeostasis |
| Q39160959 | TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy |
| Q35070525 | TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophages |
| Q37636630 | TAM receptors Tyro3 and Mer as novel targets in colorectal cancer. |
| Q47701436 | Targeting Gas6/TAM in cancer cells and tumor microenvironment |
| Q35904042 | The AXL Receptor is a Sensor of Ligand Spatial Heterogeneity |
| Q89127025 | The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation |
| Q27928010 | The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy |
| Q37073027 | The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity |
| Q54298179 | The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. |
| Q41071219 | The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer. |
| Q90745873 | The role of phosphatidylserine recognition receptors in multiple biological functions |
| Q26823237 | Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer |
| Q41936403 | Viral Infection Sensitizes Human Fetal Membranes to Bacterial Lipopolysaccharide by MERTK Inhibition and Inflammasome Activation. |
Search more.